Curanex Pharmaceuticals Inc Cash and Cash Equivalents
Curanex Pharmaceuticals Inc (CURX) had Cash and Cash Equivalents of $2.94 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $2.94M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $4.00M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $5.00M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $5.80M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $2.94M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.00M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $5.00M 10-K · filed 2026-03-30 |
| 2025-09-30 | $5.80M 10-Q · filed 2025-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |